Plants - Drugs Mind - Spirit Freedom - Law Arts - Culture Library  
References Database

References Search
All References with Titles containing 'metachlorophenylpiperazine OR mcpp OR mchlorophenylpiperazine' OR with Authors including 'metachlorophenylpiperazine OR mcpp OR mchlorophenylpiperazine' OR with Abstract including 'metachlorophenylpiperazine OR mcpp OR mchlorophenylpiperazine' OR with Keywords including 'metachlorophenylpiperazine OR mcpp OR mchlorophenylpiperazine'

Author Title JournalName Year   D
Click on Column Headers to Re-Sort The Current List
Samanin R, Mennini T, Fer... m-Chlorophenylpiperazine: A Central Serotonin Agonist Causing Powerful... Naunyn-Schmiedeberg'... 1979
Aloi JA, Insel TR, Muelle... Neuroendocrine and Behavioral Effects of m-Chlorophenylpiperazine Admi... Life Sciences 1984
McKenney JD, Glennon RA TFMPP May Produce its Stimulus Effects Via a 5-HT1B Mechanism Pharmacology Biochem... 1986
Charney DS, Woods SW, Goo... Serotonin function in anxiety II. Effects of the serotonin agonist MCP... Psychopharmacology B... 1987
Charney DS, Goodman WK, P... Serotonin function in obsessive-compulsive disorder A comparison of th... Arch Gen Psychiatry 1988
Schechter MD Use of TFMPP stimulus properties as a model of 5-HT1B receptor activat... Pharmacol Biochem Be... 1988
Kahn RS, Wetzler S, Asnis... Effects of m-chlorophenylpiperazine in normal subjects: a dose-respons... Psychopharmacology (... 1990
Frambes NA, Kirstein CL, ... 5-HT1A, 5-HT1B and 5-HT2 receptor agonists induce differential behavio... Eur J Pharmacol 1990
Chaouloff F, Laude D, Bau... Effects of the 5-HT1C/5-5-HT2 receptor agonists DOI and alpha-methyl-5... Eur J Pharmacol 1990
Boja JW, Schechter MD Possible serotonergic and dopaminergic mediation of the N-ethyl-3,4-me... Eur J Pharmacol 1991
Chaouloff F, Baudrie V, L... The 5-HT2 receptor agonist 1-2,5-dimethoxy-4-iodophenyl2-aminopropane ... Eur J Pharmacol 1992
Chaouche-Teyara K, Fourni... Vascular and cardiac effects of alpha-methyl-5-HT and DOI are mediated... Eur J Pharmacol 1993
Rotzinger S, Fang J, Bake... Trazodone is metabolized to m-chlorophenylpiperazine by CYP3A4 from hu... Drug Metab Dispos 1998
Leone M, Attanasio A, Cro... The serotonergic agent m-chlorophenylpiperazine induces migraine attac... Neurology 2000
Baumann MH, Ayestas MA, D... 1-(m-chlorophenyl)piperazine (mCPP) dissociates in vivo serotonin rele... Neuropsychopharmacol... 2001
Tancer, ME, Johanson, C-E The subjective effects of MDMA and mCPP in moderate MDMA users Drug and Alcohol Dep... 2001
Rothman R, Baumann M Therapeutic and adverse actions of serotonin transporter substrates Pharmacol Ther 2002
Gobbi M, Moia M, Pirona L... p-Methylthioamphetamine and 1-(m-chlorophenyl)piperazine, two non-neur... J Neurochem 2002
Taffe MA, Davis SA, Yuan ... Cognitive performance of MDMA-treated rhesus monkeys: sensitivity to s... Neuropsychopharmacol... 2002
Peters FT, Schaefer S, St... Screening for and validated quantification of amphetamines and of amph... J Mass Spectrom 2003
Taffe MA, Huitron-Resendi... MDMA exposure alters cognitive and electrophysiological sensitivity to... Pharmacol Biochem Be... 2003
Tancer M, Johanson CE Reinforcing, subjective, and physiological effects of MDMA in humans: ... Drug Alcohol Depend 2003
Maurer HH, Kraemer T, Spr... Chemistry, pharmacology, toxicology, and hepatic metabolism of designe... Ther Drug Monit 2004
Feuchtl A, Bagli M, Steph... Pharmacokinetics of m-chlorophenylpiperazine after intravenous and ora... Pharmacopsychiatry 2004
Staack RF, Maurer HH Metabolism of designer drugs of abuse Curr Drug Metab 2005
Bossong MG, Van Dijk JP, ... Methylone and mCPP, two new drugs of abuse? Addict Biol 2005
Johanson CE, Kilbey M, Ga... Discriminative stimulus effects of 3,4-methylenedioxymethamphetamine (... Drug Alcohol Depend 2006
Vogels N, Brunt TM, Rigte... Content of ecstasy in the Netherlands: 1993-2008 Addiction 2009
Bossong MG, Brunt TM, Van... mCPP: an undesired addition to the ecstasy market J Psychopharmacol 2010
Brunt TM, Koeter MW, Nies... Linking the pharmacological content of ecstasy tablets to the subjecti... Psychopharmacology (... 2011
Arbo MD, Bastos ML, Carmo... Piperazine compounds as drugs of abuse Drug Alcohol Depend 2011
Castelli R2, Thornton SL,... True or False? Analysis of phencyclidine positive urine drug immunoass... NAACT Abstract 2015
Adamowicz P, Gieron J, Gi... The prevalence of new psychoactive substances in biological material -... Drug Test Anal 2015
Odoardi S, Romolo FS, Str... A snapshot on NPS in Italy: Distribution of drugs in seized materials ... Forensic Sci Int 2016